Tarsus (NASDAQ:TARS) announced it will host a live webcast on Thursday, August 6, 2026, at 5:00 a.m. PT / 8:00 a.m. ET to report its second quarter 2026 financial results and provide a corporate update. A recorded version will be available on the company’s website for about 90 days after the webcast.
Loading...
Loading translation...
Positive
None.
Negative
None.
Market Context
The two prior earnings-date notices were followed by 4.85% and 0.78% 24-hour moves, providing a dire...
Analysis
The two prior earnings-date notices were followed by 4.85% and 0.78% 24-hour moves, providing a directly comparable record. Recent insider context was Net Selling; the webcast and results date remain the next factual checkpoints.
IRVINE, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 5:00 a.m. PT / 8:00 a.m. ET on Thursday, August 6, 2026 to report its second quarter 2026 financial results and provide a corporate update.
Participants may access the webcast here. A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days.
About Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of ocular rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease, both of which are in Phase 2, and IRX-101 for potential use as an ocular antiseptic.
Investor Contact: David Nakasone Head of Investor Relations (949) 620-3223 DNakasone@tarsusrx.com
FAQ
When will Tarsus (NASDAQ:TARS) report its Q2 2026 financial results?
Tarsus will report its Q2 2026 results on Thursday, August 6, 2026 via a live webcast. According to Tarsus, the webcast starts at 5:00 a.m. PT / 8:00 a.m. ET and includes a corporate update.
What time is the Tarsus (TARS) Q2 2026 earnings webcast on August 6, 2026?
The Tarsus Q2 2026 webcast begins at 5:00 a.m. PT / 8:00 a.m. ET. According to Tarsus, the event will cover second quarter 2026 financial results and a corporate update for investors and other interested participants.
How can investors access the Tarsus (TARS) Q2 2026 financial results webcast?
Investors can access the Tarsus Q2 2026 webcast through an online link described as “here.” According to Tarsus, the webcast will be available live, with a recorded version posted on the company website afterward.
Will a replay be available for the Tarsus (TARS) Q2 2026 earnings call?
Yes, a replay of the Tarsus Q2 2026 webcast will be available on the company website. According to Tarsus, the recorded version will be archived for approximately 90 days after the completion of the event.
What will Tarsus (NASDAQ:TARS) discuss during the August 6, 2026 webcast?
Tarsus plans to discuss its second quarter 2026 financial results and provide a corporate update. According to Tarsus, this live webcast gives investors insight into recent financial performance and current corporate developments.